arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

SI-BONE, Inc.

SIBN
$18.14 ▲ +0.10 (+0.55%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
37 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
33
Health
Poor
Bearish
auto_awesome

Analytical Summary

SI-BONE, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $797.4M
Dividend Yield
Revenue Growth 11.2%
Op. Margin -9.7%
ROIC -1.9%
FCF / Share $-0.08
Trailing P/E
Price / Book 4.5x
FCF Yield
Debt / Equity 0.20
info Valuation on last close. End-of-day price, Aug 6, 2026.

37-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$52.59M
↑ +11.2%
Net Income Profit after all expenses
$-4.33M
↑ +33.8%
Operating Margin Operating profit as % of sales
-9.7%
↓ -121.6% 14th
FCF / Share Free cash flow per share
$-0.08
↑ +52.6%
Long-Term Debt Long-term obligations
$35.60M
— +0.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
16
Returns
34
Financial Health
52
Cash Quality
39

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 37 quarters